07 Dec 2022 --- Cell rejuvenation company Turn Bio is presenting its pre-clinical data suggesting that its proprietary mRNA platform technology, Epigenetic Reprogramming of Aging (ERA) treatment for skin rejuvenation, may be more effective than combination therapies presently used.“The data suggest we may be close to redefining the care dermatologists can provide their patients,” says Jill Waibel, a board-certified dermatologist and regenerative medicine researcher who presented findings at the Global Aesthetics Conference.
